Published in Neurology on September 19, 2012
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation. Eur Heart J (2014) 1.54
New oral anticoagulants may be particularly useful for asian stroke patients. J Stroke (2014) 1.00
Novel anticoagulants for stroke prevention in atrial fibrillation: a systematic review of cost-effectiveness models. PLoS One (2013) 0.93
Warfarin treatment among Finnish patients with atrial fibrillation: retrospective registry study based on primary healthcare data. BMJ Open (2014) 0.92
New oral anticoagulants for atrial fibrillation: are they worth the risk? P T (2014) 0.87
Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient. Int J Gen Med (2013) 0.83
Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands. PLoS One (2014) 0.82
Carotid artery stenosis: cost-effectiveness of assessment of cerebrovascular reserve to guide treatment of asymptomatic patients. Radiology (2014) 0.79
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation. Cardiol Ther (2016) 0.78
Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions. Drugs Context (2013) 0.78
Cost-Effectiveness of Carotid Plaque MR Imaging as a Stroke Risk Stratification Tool in Asymptomatic Carotid Artery Stenosis. Radiology (2015) 0.78
A clinician's perspective: novel oral anticoagulants to reduce the risk of stroke in nonvalvular atrial fibrillation--full speed ahead or proceed with caution? Vasc Health Risk Manag (2014) 0.77
Effect of rivaroxaban versus warfarin on health care costs among nonvalvular atrial fibrillation patients: observations from rivaroxaban users and matched warfarin users. Adv Ther (2015) 0.76
Cardioembolic Stroke. Circ Res (2017) 0.75
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med (2009) 11.49
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med (1994) 10.26
Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA (1996) 8.52
Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med (2010) 8.28
Warfarin, aspirin, or both after myocardial infarction. N Engl J Med (2002) 6.85
Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation (2004) 4.45
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med (2010) 4.16
Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke (2003) 3.56
Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial. Lancet Neurol (2010) 3.26
Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA (1995) 3.21
Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA (2002) 2.94
Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation. Circulation (2011) 2.80
Acutely injured patients on dabigatran. N Engl J Med (2011) 2.05
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. Lancet Neurol (2012) 1.99
Utilization of acute care services in the year before and after first stroke: A population-based study. Neurology (1996) 1.77
Inpatient costs of specific cerebrovascular events at five academic medical centers. Neurology (1996) 1.40
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack. Stroke (2012) 1.15
The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry. Am Heart J (2006) 1.10
Evaluating rivaroxaban for nonvalvular atrial fibrillation--regulatory considerations. N Engl J Med (2011) 0.98
Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels. Am Heart J (2001) 0.96
Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial. Am Heart J (2008) 0.94
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med (2013) 8.76
Should the Babinski sign be part of the routine neurologic examination? Neurology (2005) 5.57
Midlife cardiovascular risk factors and risk of dementia in late life. Neurology (2005) 5.12
Transient ischemic attack--proposal for a new definition. N Engl J Med (2002) 4.94
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet (2010) 4.72
Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med (2003) 4.72
The beautiful and ethereal neurological exam: an appeal for research. Ann Neurol (2011) 4.10
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke (2005) 3.74
Risk of stroke in children: ethnic and gender disparities. Neurology (2003) 3.47
Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100. Neurology (2012) 3.20
Global variation in the relative burden of stroke and ischemic heart disease. Circulation (2011) 3.02
Financial anatomy of neuroscience research. Ann Neurol (2006) 2.71
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56
NIH disease funding levels and burden of disease. PLoS One (2011) 2.56
Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke (2004) 2.42
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation (2005) 2.38
Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics (2007) 2.29
Head computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke (2003) 2.28
Racial/Ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke (2007) 2.26
Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol (2006) 2.17
Influence of physician specialty on outcomes after acute ischemic stroke. J Hosp Med (2008) 2.07
Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.06
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. Circulation (2008) 2.05
Getting youth in the game: can we accelerate training for clinician-scientists? Ann Neurol (2010) 2.04
Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive. Stroke (2013) 2.01
Recent trauma and acute infection as risk factors for childhood arterial ischemic stroke. Ann Neurol (2012) 1.94
Moyamoya disease in Washington State and California. Neurology (2005) 1.88
Clinical- and imaging-based prediction of stroke risk after transient ischemic attack: the CIP model. Stroke (2008) 1.88
Intracranial atherosclerotic disease: an update. Ann Neurol (2009) 1.86
Thirty-year projections for deaths from ischemic stroke in the United States. Stroke (2003) 1.86
Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival. Stroke (2011) 1.84
Declining stroke rates in Californian children with sickle cell disease. Blood (2004) 1.83
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale. Am Heart J (2010) 1.82
Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals. Stroke (2002) 1.80
Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke (2003) 1.78
Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke (2005) 1.78
Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke (2004) 1.74
Predictors and outcomes of intraprocedural rupture in patients treated for ruptured intracranial aneurysms: the CARAT study. Stroke (2008) 1.72
A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke. Stroke (2011) 1.72
Translational research for a new administration: what sort of change to believe in? Ann Neurol (2008) 1.71
Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Stroke (2010) 1.71
Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial. Bull World Health Organ (2009) 1.70
Application of the ABCD2 score to identify cerebrovascular causes of dizziness in the emergency department. Stroke (2012) 1.65
Recruiting subjects for acute stroke trials: a meta-analysis. Stroke (2005) 1.65
Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 1.64
Association between major perioperative hemorrhage and stroke or Q-wave myocardial infarction. Circulation (2012) 1.58
Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke (2009) 1.56
Imaging data reveal a higher pediatric stroke incidence than prior US estimates. Stroke (2009) 1.56
Neurological disease on the global agenda. Ann Neurol (2008) 1.56
High critical care usage due to pediatric stroke: results of a population-based study. Neurology (2012) 1.56
Financing of U.S. biomedical research and new drug approvals across therapeutic areas. PLoS One (2009) 1.55
Are patients with acutely recovered cerebral ischemia more unstable? Stroke (2003) 1.54
Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. Am J Epidemiol (2010) 1.53
Recurrent hemorrhagic stroke in children: a population-based cohort study. Stroke (2007) 1.51
The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease. Eur Heart J (2009) 1.49
The dangers of clinical conviction: an "M&M" of endovascular therapies for stroke. Ann Neurol (2013) 1.48
Why are eligible thrombolysis candidates left untreated? Am J Prev Med (2006) 1.45
Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke (2009) 1.44
4-aminopyridine: new life for an old drug. Ann Neurol (2010) 1.43
Journeys in complex genetics: music and mental illness. Ann Neurol (2009) 1.39
Electronic medical records: does it take a village or a thousand points of light? Ann Neurol (2008) 1.39
That vexing problem of compensation. Ann Neurol (2008) 1.39
Safety and feasibility of a CT protocol for acute stroke: combined CT, CT angiography, and CT perfusion imaging in 53 consecutive patients. AJNR Am J Neuroradiol (2003) 1.37
Addition of brain infarction to the ABCD2 Score (ABCD2I): a collaborative analysis of unpublished data on 4574 patients. Stroke (2010) 1.35
Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol (2006) 1.33
Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure. J Womens Health (Larchmt) (2004) 1.32
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design. Int J Stroke (2013) 1.29
Higher ABCD2 score predicts patients most likely to have true transient ischemic attack. Stroke (2008) 1.28
A status report on neuroscience research, without grade inflation. Ann Neurol (2006) 1.24
The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke. Stroke (2012) 1.24
Effect of presenting hemorrhage on outcome after microsurgical resection of brain arteriovenous malformations. Neurosurgery (2005) 1.22
Profiles of lacunar and nonlacunar stroke. Ann Neurol (2011) 1.19
Basic and clinical research: what is the most appropriate weighting in a public investment portfolio? Ann Neurol (2006) 1.18
How accurate is CT angiography in evaluating intracranial atherosclerotic disease? Stroke (2008) 1.16
External validation of the ICH score. Neurocrit Care (2004) 1.16
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack. Stroke (2012) 1.15
Prevalence and predictors of perinatal hemorrhagic stroke: results from the kaiser pediatric stroke study. Pediatrics (2009) 1.14